Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Special Issue 4 (2022)

Comparative efficacy of doxycycline and imidocarb diprionate in treatment of ehrlichiosis in dogs

Author(s):
L Narayana Rao, B Shobhamani, V Vaikunta Rao and KV Subramanyam
Abstract:
Retrospective study evaluated the efficacy of Doxycycline and Imidocarb dipropionate in ehrlichia infected dogs. Based on history, clinical signs, peripheral blood smears examination, buffy coat smear examination, anigen Rapid E.canis Ab Test kit, and nested PCR, 17 dogs were diagnosed as canine ehrlichiosis among them Twelve dogs were randomly selected into 2 groups; Group II : Doxycycline and lactic acid bacillus (Doxypet) @10mg/kg b.wt. Per orally once in a day (n=6), Group III: Imidocarb dipropionate 12%w/v injection (Imicarb) @6.6 mg/kg b.wt, intramuscularly twice 14 days apart (n=6). The results revealed that magnitude of improvement and reversal of normalcy in certain clinical and various haemato biochemical parameters was far greater in Group II than Group III.
Pages: 1304-1309  |  730 Views  527 Downloads
How to cite this article:
L Narayana Rao, B Shobhamani, V Vaikunta Rao and KV Subramanyam. Comparative efficacy of doxycycline and imidocarb diprionate in treatment of ehrlichiosis in dogs. The Pharma Innovation Journal. 2022; 11(4S): 1304-1309.

Call for book chapter